Publication | Closed Access

Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer

OncologyMedicinePathologyCancer GenomicsBronchial NeoplasmCancer TreatmentCancer GeneticsPharmacologyRadiation OncologyEgfr MutationLung Cancer